These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 31757619)

  • 1. Escitalopram ameliorates differences in neural activity between healthy comparison and major depressive disorder groups on an fMRI Emotional conflict task: A CAN-BIND-1 study.
    Alders GL; Davis AD; MacQueen G; Strother SC; Hassel S; Zamyadi M; Sharma GB; Arnott SR; Downar J; Harris JK; Lam RW; Milev R; Müller DJ; Ravindran A; Kennedy SH; Frey BN; Minuzzi L; Hall GB;
    J Affect Disord; 2020 Mar; 264():414-424. PubMed ID: 31757619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced accuracy accompanied by reduced neural activity during the performance of an emotional conflict task by unmedicated patients with major depression: A CAN-BIND fMRI study.
    Alders GL; Davis AD; MacQueen G; Strother SC; Hassel S; Zamyadi M; Sharma GB; Arnott SR; Downar J; Harris JK; Lam RW; Milev R; Müller DJ; Ravindran A; Kennedy SH; Frey BN; Minuzzi L; Hall GB;
    J Affect Disord; 2019 Oct; 257():765-773. PubMed ID: 31400735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early post-treatment blood oxygenation level-dependent responses to emotion processing associated with clinical response to pharmacological treatment in major depressive disorder.
    Williams RJ; Brown EC; Clark DL; Pike GB; Ramasubbu R
    Brain Behav; 2021 Aug; 11(8):e2287. PubMed ID: 34333866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping the effect of escitalopram treatment on amplitude of low-frequency fluctuations in patients with depression: a resting-state fMRI study.
    Wang L; Li X; Li K; Su Y; Zeng Y; Zhang Q; Wang G; Jin Z; Kong Q; Si T
    Metab Brain Dis; 2017 Feb; 32(1):147-154. PubMed ID: 27524655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report.
    Suh JS; Minuzzi L; Raamana PR; Davis A; Hall GB; Harris J; Hassel S; Zamyadi M; Arnott SR; Alders GL; Sassi RB; Milev R; Lam RW; MacQueen GM; Strother SC; Kennedy SH; Frey BN
    Neuroimage Clin; 2020; 25():102178. PubMed ID: 32036277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term escitalopram treatment normalizes aberrant self-referential processing in major depressive disorder.
    Komulainen E; Heikkilä R; Nummenmaa L; Raij TT; Harmer CJ; Isometsä E; Ekelund J
    J Affect Disord; 2018 Aug; 236():222-229. PubMed ID: 29747140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram enhances synchrony of brain responses during emotional narratives in patients with major depressive disorder.
    Komulainen E; Glerean E; Heikkilä R; Nummenmaa L; Raij TT; Isometsä E; Ekelund J
    Neuroimage; 2021 Aug; 237():118110. PubMed ID: 33933596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of escitalopram on regional brain function in first-episode drug-naive patients with major depressive disorder assessed by resting-state functional magnetic resonance imaging.
    Wang L; Li K; Zhang Q; Zeng Y; Dai W; Su Y; Wang G; Tan Y; Jin Z; Yu X; Si T
    Psychol Med; 2014 May; 44(7):1417-26. PubMed ID: 23942213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State-Dependent Differences in Emotion Regulation Between Unmedicated Bipolar Disorder and Major Depressive Disorder.
    Rive MM; Mocking RJ; Koeter MW; van Wingen G; de Wit SJ; van den Heuvel OA; Veltman DJ; Ruhé HG; Schene AH
    JAMA Psychiatry; 2015 Jul; 72(7):687-96. PubMed ID: 25945779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of antidepressant treatment on long-range and short-range functional connectivity strength in patients with major depressive disorder.
    An J; Wang L; Li K; Zeng Y; Su Y; Jin Z; Yu X; Si T
    Sci Rep; 2017 Aug; 7(1):10214. PubMed ID: 28860564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medial prefrontal cortex activity during memory encoding of pictures and its relation to symptomatic improvement after citalopram treatment in patients with major depression.
    Roy M; Harvey PO; Berlim MT; Mamdani F; Beaulieu MM; Turecki G; Lepage M
    J Psychiatry Neurosci; 2010 May; 35(3):152-62. PubMed ID: 20420766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural predictors and effects of cognitive behavioral therapy for depression: the role of emotional reactivity and regulation.
    Rubin-Falcone H; Weber J; Kishon R; Ochsner K; Delaparte L; Doré B; Raman S; Denny BT; Oquendo MA; Mann JJ; Miller JM
    Psychol Med; 2020 Jan; 50(1):146-160. PubMed ID: 30739618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bipolar I disorder and major depressive disorder show similar brain activation during depression.
    Cerullo MA; Eliassen JC; Smith CT; Fleck DE; Nelson EB; Strawn JR; Lamy M; DelBello MP; Adler CM; Strakowski SM
    Bipolar Disord; 2014 Nov; 16(7):703-12. PubMed ID: 24990479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic connectomes are a predictive biomarker of remission in major depressive disorder.
    Korgaonkar MS; Goldstein-Piekarski AN; Fornito A; Williams LM
    Mol Psychiatry; 2020 Jul; 25(7):1537-1549. PubMed ID: 31695168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural correlates of processing emotional prosody in unipolar depression.
    Koch K; Stegmaier S; Schwarz L; Erb M; Reinl M; Scheffler K; Wildgruber D; Ethofer T
    Hum Brain Mapp; 2018 Aug; 39(8):3419-3427. PubMed ID: 29682814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bupropion extended release on negative emotion processing in major depressive disorder: a pilot functional magnetic resonance imaging study.
    Robertson B; Wang L; Diaz MT; Aiello M; Gersing K; Beyer J; Mukundan S; McCarthy G; Doraiswamy PM
    J Clin Psychiatry; 2007 Feb; 68(2):261-7. PubMed ID: 17335325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment brain states identify likely nonresponse to standard treatments for depression.
    McGrath CL; Kelley ME; Dunlop BW; Holtzheimer PE; Craighead WE; Mayberg HS
    Biol Psychiatry; 2014 Oct; 76(7):527-35. PubMed ID: 24462230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the regional cerebral blood flow detected by arterial spin labeling after 6-week escitalopram treatment for major depressive disorder.
    Kaichi Y; Okada G; Takamura M; Toki S; Akiyama Y; Higaki T; Matsubara Y; Okamoto Y; Yamawaki S; Awai K
    J Affect Disord; 2016 Apr; 194():135-43. PubMed ID: 26826533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of pretreatment neural activity in the visual cortex during emotional processing to predict treatment response to scopolamine in major depressive disorder.
    Furey ML; Drevets WC; Hoffman EM; Frankel E; Speer AM; Zarate CA
    JAMA Psychiatry; 2013 Mar; 70(3):280-90. PubMed ID: 23364679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder.
    Grimm S; Keicher C; Paret C; Niedtfeld I; Beckmann C; Mennes M; Just S; Sharma V; Fuertig R; Herich L; Mack S; Thamer C; Schultheis C; Weigand A; Schmahl C; Wunder A
    Eur Neuropsychopharmacol; 2022 Dec; 65():44-51. PubMed ID: 36343427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.